“The Zydus group firm’s board ... approved issuing equity shares of face value of Rs 10 each on a preferential basis to Cadila Healthcare, True North, Pioneer Investment Fund and Zydus Family Trust, Zydus Wellness said in a filing to the BSE,” reported The Times of India.
Shardul Amarchand Mangaldas & Co advised
Deal value: US$ 140 million
2018-12-06
This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.
No comments yet: share your views